Your browser doesn't support javascript.
loading
ERBB2 emerges as a new target for colorectal cancer.
Pectasides, Eirini; Bass, Adam J.
Afiliação
  • Pectasides E; Division of Hematology and Oncology, Beth Israel Deaconess Hospital, Boston, Massachusetts. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Bass AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Broad Institute of MIT and Harvard, Cambridge, Massachusetts. Departments of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts. Adam_Bass@dfci.harvard.edu.
Cancer Discov ; 5(8): 799-801, 2015 Aug.
Article em En | MEDLINE | ID: mdl-26243861

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Receptor ErbB-2 / Mutação Limite: Animals / Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Receptor ErbB-2 / Mutação Limite: Animals / Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2015 Tipo de documento: Article